Drugs / Platelet transfusion
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT03045068 | Apr 2017 → Oct 2018 | cardiac rhythm disease, cardiac valvular defect | The University of Texas Health Science Center, Houston | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT03090919 | Jan 2017 → May 2021 | infectious disease with sepsis, thrombocytopenia | Susan Smyth | Withdrawn | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04807621 Comparator | Mar 2018 → Jan 2022 | congenital heart disease | Sahlgrenska University Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Platelet transfusion | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04807621 ↗ |
| Known as | Platelet | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03045068 ↗ |
| Route | Intravenous | “via a central venous line” NCT03045068 ↗ |